What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353

Cahill executed a sale of 4,170 shares on Aug. 6, 2026, realizing ~$389,353 in transaction value.

The disposition reduced his total equity holdings by 6%, including shares acquired via option exercise, and 13% of his direct ownership.

The transaction involved the exercise of 4,170 stock options at $71.56 per share, while 36,357 shares remain held indirectly by a trust.

Following the trade, the director maintains a total equity position valued at $6.02 million as of the Aug. 6, 2026, market close.

John T. Cahill, Director of Colgate-Palmolive Company (NYSE:CL) , reported a sale of 4,170 shares of Common Stock on Aug. 6, 2026, as disclosed in an SEC Form 4 filing .

Transaction value based on SEC Form 4 weighted average sale price ($93.37); post-transaction value based on Aug. 6, 2026, market close ($93.00).

Colgate-Palmolive is a multinational consumer goods manufacturer with a market capitalization of $74.6 billion and TTM revenue of $21.0 billion, positioning it as a significant player in the household and personal products sector. The company maintains competitive advantages through its portfolio of globally recognized brands, established distribution infrastructure, and diversified product offerings across oral care, personal care, and pet nutrition categories. With 33,600 employees and operations spanning multiple geographic regions, Colgate-Palmolive leverages scale and brand equity to sustain market leadership in the consumer defensive sector.

Simply put, investors shouldn’t fret over this sale. The transaction by Director Cahill was part of a prearranged option exercise and sale that doesn’t indicate any market timing or judgment regarding Colgate Palmolive stock.